These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12779240)

  • 1. Cis-[Pt(Cl)2(pyridine)(5-SO3H-isoquinoline)] complex, a selective inhibitor of telomerase enzyme.
    Colangelo D; Ghiglia AL; Viano I; Cavigiolio G; Osella D
    Biometals; 2003 Dec; 16(4):553-60. PubMed ID: 12779240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Might telomerase enzyme be a possible target for trans-Pt(II) complexes?
    Colangelo D; Ghiglia A; Viano I; Mahboobi H; Ghezzi A; Cassino C; Osella D
    J Inorg Biochem; 2004 Jan; 98(1):61-7. PubMed ID: 14659633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel platinum compound inhibits telomerase activity in vitro and reduces telomere length in a human hepatoma cell line.
    Furuta M; Nozawa K; Takemura M; Izuta S; Murate T; Tsuchiya M; Yoshida K; Taka N; Nimura Y; Yoshida S
    Int J Cancer; 2003 May; 104(6):709-15. PubMed ID: 12640677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells.
    Zhang RG; Zhang RP; Wang XW; Xie H
    Cell Res; 2002 Mar; 12(1):55-62. PubMed ID: 11942411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells.
    Liu WJ; Zhang YW; Shen Y; Jiang JF; Miao ZH; Ding J
    Biochem Biophys Res Commun; 2004 Oct; 323(2):660-7. PubMed ID: 15369801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells.
    Binz N; Shalaby T; Rivera P; Shin-ya K; Grotzer MA
    Eur J Cancer; 2005 Dec; 41(18):2873-81. PubMed ID: 16253503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.
    Herbert BS; Pongracz K; Shay JW; Gryaznov SM
    Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner.
    Frink RE; Peyton M; Schiller JH; Gazdar AF; Shay JW; Minna JD
    Oncotarget; 2016 May; 7(22):31639-51. PubMed ID: 27192120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of human telomeric G-quadruplex and inhibition of telomerase activity by propeller-shaped trinuclear Pt(II) complexes.
    Xu CX; Shen Y; Hu Q; Zheng YX; Cao Q; Qin PZ; Zhao Y; Ji LN; Mao ZW
    Chem Asian J; 2014 Sep; 9(9):2519-26. PubMed ID: 24996049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A highly selective telomerase inhibitor limiting human cancer cell proliferation.
    Damm K; Hemmann U; Garin-Chesa P; Hauel N; Kauffmann I; Priepke H; Niestroj C; Daiber C; Enenkel B; Guilliard B; Lauritsch I; Müller E; Pascolo E; Sauter G; Pantic M; Martens UM; Wenz C; Lingner J; Kraut N; Rettig WJ; Schnapp A
    EMBO J; 2001 Dec; 20(24):6958-68. PubMed ID: 11742973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of telomerase inhibitors.
    Kleideiter E; Piotrowska K; Klotz U
    Methods Mol Biol; 2007; 405():167-80. PubMed ID: 18369824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
    Raymond E; Faivre S; Dieras V; Von Hoff D
    Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth arrest, apoptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telomerase inhibitor.
    Shammas MA; Koley H; Beer DG; Li C; Goyal RK; Munshi NC
    Gastroenterology; 2004 May; 126(5):1337-46. PubMed ID: 15131795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines.
    Parsch D; Brassat U; Brümmendorf TH; Fellenberg J
    Cancer Invest; 2008 Jul; 26(6):590-6. PubMed ID: 18584350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agents that target telomerase and telomeres.
    Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD
    Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells.
    Chen Z; Koeneman KS; Corey DR
    Cancer Res; 2003 Sep; 63(18):5917-25. PubMed ID: 14522918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct modulation of telomere length in two T-lymphoblastic leukemia cell lines by cytotoxic nucleoside phosphonates PMEG and PMEDAP.
    Hájek M; Cvilink V; Votruba I; Holý A; Mertlíková-Kaiserová H
    Eur J Pharmacol; 2010 Sep; 643(1):6-12. PubMed ID: 20599933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cells.
    Kim JH; Kim JH; Lee GE; Kim SW; Chung IK
    Biochem J; 2003 Jul; 373(Pt 2):523-9. PubMed ID: 12689331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase.
    Gomez D; Aouali N; Renaud A; Douarre C; Shin-Ya K; Tazi J; Martinez S; Trentesaux C; Morjani H; Riou JF
    Cancer Res; 2003 Oct; 63(19):6149-53. PubMed ID: 14559794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.